Effect of Kang'ai injection on hepatic fibrosis in rats.
- Author:
Xinmei XIE
1
;
Rui PANG
;
Fanye ZENG
;
Hongliang ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Drugs, Chinese Herbal; administration & dosage; Female; Humans; Liver; drug effects; pathology; Liver Cirrhosis; drug therapy; pathology; Male; Rats; Rats, Wistar
- From: China Journal of Chinese Materia Medica 2012;37(16):2469-2471
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the inhibition role of Kang'ai injection (KAI) in rats with hepatic fibrosis.
METHODAnimal model with liver fibrosis were induced by 0.01% concentration of diethylnitrosamine (DEN). 30 female Wistar rats (160-200 g) were randomly divided into 3 groups: the KAI-DEN group, the DEN group and the blank control group. The KAI-DEN group was administered Kang'ai injection (1 mL x k(-1), intraperitoneal injection, once a week) and the DEN group was administered normal saline intraperitoneal injection. HE staining and VG special staining of liver tissue were used to evaluate liver fibrosis.
RESULTCompared with the DEN group, relatively less structural damage and less pseudolobular formation in the KAI-DEN group. Collagen area of the blank control group, the KAI-DEN group and the DEN group were (6.52 +/- 2.64)% , (17.41 +/- 1.112)% and (20.180 +/- 2.519)% , respectively. The difference was statistically significant, P < 0.05.
CONCLUSIONKang'ai injection could inhibit the formation of DEN-induced liver fibrosis.
